DARE as of Oct 31 · 04:30 ET
DARENasdaqPharmaceutical Preparations

Dare Bioscience, Inc. · Brief

Next report

12 days

Nov 12 · after closeest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26—▼−32.12%—
quarterimplied−35%0+35%realized×
Q2 FY26—▼−32.12%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 12 report · est.

Bull2 of 3

5disclosed supplier and customer ties in SEC filingsSEC filings
27managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

5managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
3 of 18of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

DARE report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.